Pharmaceuticals New Zealand

New Zealand Peritoneal Dialysis Solutions Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

New Zealand Peritoneal Dialysis Solutions Market Industry Trends and Forecast to 2034: Segmented by (Product, Mode, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

New Zealand · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $46.9 Mn Placeholder estimate
Estimate 2025 $49.9 Mn 1.1% of the global market
Projected 2034 $87.3 Mn 74.8% Adds $37.3 Mn over 9 forecast years
CAGR 2025–2034 6.4% Faster than 27% of 160 Pharmaceuticals markets here
Key players 5
  • New Zealand is 1.11% of the global market.
  • In APAC, the largest is China at $352.8 Mn.
  • Fastest growing: India at 9.3% a year.
  • New Zealand ranks 5th of 10 by size in APAC.

Market size projection

New Zealand

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$37.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Peritoneal Dialysis Solutions Market market size by year, New Zealand
YearMarket sizeChange that yearSince 2025
2024 (estimate) $46.9 Mn — —
2025 (base) $49.9 Mn +$3.0 Mn —
2026 (forecast) $53.1 Mn +$3.2 Mn +6.4%
2027 (forecast) $56.5 Mn +$3.4 Mn +13.2%
2028 (forecast) $60.1 Mn +$3.6 Mn +20.5%
2029 (forecast) $64.0 Mn +$3.8 Mn +28.2%
2030 (forecast) $68.1 Mn +$4.1 Mn +36.4%
2031 (forecast) $72.4 Mn +$4.4 Mn +45.1%
2032 (forecast) $77.1 Mn +$4.6 Mn +54.4%
2033 (forecast) $82.0 Mn +$4.9 Mn +64.3%
2034 (forecast) $87.3 Mn +$5.2 Mn +74.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

New Zealand Peritoneal Dialysis Solutions Market Analysis at a glance
Market size, 2025$49.9 Mn placeholder estimate
Forecast, 2034$87.3 Mn placeholder estimate
Growth (CAGR), 2025–20346.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, mode and end user (see all)
Key playersBaxter International, Fresenius Medical Care, B. Braun, Terumo Corporation, JMS Co. (see all)
Regulator in New ZealandMedsafeSource: Medsafe. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The New Zealand Peritoneal Dialysis Solutions Market Analysis Executive Summary

Peritoneal dialysis solutions are sterile fluids used to clean the blood through the belly lining in home dialysis.

Key segments of the peritoneal Dialysis Solutions market include product (Glucose-Based Solutions, Icodextrin Solutions and Amino Acid Solutions) and mode (Continuous Ambulatory PD and Automated PD).

Bar chart: New Zealand Peritoneal Dialysis Solutions market size, 2024–2034, placeholder estimates. $46.9 Mn in 2024, $49.9 Mn in 2025 and $87.3 Mn in 2034, 6.4% CAGR.
New Zealand Peritoneal Dialysis Solutions market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

New Zealand Peritoneal Dialysis Solutions Market Dynamics

Market Growth Drivers

More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the peritoneal Dialysis Solutions market.

Opportunity

Ready-to-use formulations, biosimilars and supply security programmes give the peritoneal Dialysis Solutions market room to grow.

Market Restraints

Drug shortages, price controls, generic competition and strict hospital budgets hold back the peritoneal Dialysis Solutions market.

Competitive Landscape for Peritoneal Dialysis Solutions Market in New Zealand

The peritoneal Dialysis Solutions market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Peritoneal Dialysis Solutions Market in New Zealand

Peritoneal Dialysis Solutions in New Zealand: rules and payment

Medsafe, part of the Ministry of Health, approves medicines before they can be sold.⁠[1] Pharmac decides which medicines and medical devices the public health system pays for.⁠[2]

[1] Medsafe. Checked 14 Nov 2026.

[2] Pharmac. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for peritoneal Dialysis Solutions. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in New Zealand.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Peritoneal Dialysis Solutions right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Peritoneal Dialysis Solutions in context

New Zealand compared

  • Health spending per person: 5,022 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 3.61 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 2nd highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 17.6% of people (2025). World: 10.4% of people (2025). 4th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Peritoneal Dialysis Solutions market in New Zealand?
Placeholder estimate: about $49.9 Mn in 2025, rising to about $87.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Peritoneal Dialysis Solutions market in New Zealand growing?
Placeholder estimate: about 6.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Peritoneal Dialysis Solutions market report cover?
The report splits the market by product (Glucose-Based Solutions, Icodextrin Solutions, Amino Acid Solutions), mode (Continuous Ambulatory PD, Automated PD) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Peritoneal Dialysis Solutions market?
Key players include Baxter International, Fresenius Medical Care, B. Braun, Terumo Corporation and JMS Co..
What is driving the Peritoneal Dialysis Solutions market?
More surgery and intensive care, rising infection risks, new specialty medicines and the growth of hospital pharmacy services are driving the peritoneal Dialysis Solutions market.
Who regulates Peritoneal Dialysis Solutions in New Zealand?
Medsafe, part of the Ministry of Health, approves medicines before they can be sold. Source: Medsafe. Checked 14 Nov 2026.
How is healthcare paid for in New Zealand?
Pharmac decides which medicines and medical devices the public health system pays for. Source: Pharmac. Checked 14 Nov 2026.
How much research is published on Peritoneal Dialysis Solutions?
PubMed lists 29 papers on Peritoneal Dialysis Solutions added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in New Zealand

See all

Related on kidney health and home and long-term care

See the topic